Until yesterday, the treatment of severe hypoglycemia was a glucagon injection that involves a clunky and complicated system. Today, with FDA approving the glucagon nasal powder Baqsimi from Eli Lilly (LLY), patients with severe hypoglycemia can breathe a little easier.
Original Article: First Needle-free Treatment For Severe Hypoglycemia Gets FDA Nod